3D bioprinting technology

Navigating through the landscape of bioprinting, 2023 unfolded as a year where targeted investments significantly nurtured this specialized field. The ripples of these investments indicate a maturing industry poised for…

Bioprinting collaborations are heating up in 2023. In one of the biggest moves of the bioprinting industry, Canadian startup Aspect Biosystems and Danish pharma giant Novo Nordisk (CPH: NOVO-B) struck…

3D Systems (NYSE: DDD) spinoff Systemic Bio opened a state-of-the-art laboratory to conduct research into hydrogel scaffold manufacturing and organ-on-a-chip as part of its mission to accelerate drug discovery and…

Bioprinting machine manufacturer Inventia Life Science has opened its first U.S. office and facility at Delaware NGO The Innovation Space. The Sydney, Australia-based startup will benefit from the rich life…

After announcing a Series B round last January, Sydney-headquartered biotech startup Inventia received an additional AU$4.4 million ($3.2 million) from Australian pension fund giant HESTA. This latest investment brings Inventia’s…

BICO (STO: BICO) has purchased another bioprinting startup, adding to its now massive portfolio of 13 acquisitions. This time around, it was rapid-throughput bioprinting company Allegro 3D, a spin-off from…

In the highly competitive biotechnology and pharmaceutical industries, hardware manufacturers are under a lot of pressure to provide the best, most efficient, and fastest platforms for researchers. Bioprinting, in particular,…

Bioconvergence company Cellink partnered with 3D printing technology supplier Altem Technologies to accelerate the groundwork for life-sciences bioprinting in the Indian market. Local research institutions and hospitals can now contact…

Just days after Cellink signed its latest acquisition agreement with global system supplier Ginolis, the company has announced a new takeover, this time of MatTek. A global leader of in…

Innovative biomedical company REGENHU just launched its next-generation 3D bioprinters and software as part of its ongoing mission to revolutionize medicine. Called the R-GEN series, the new systems consolidate years…

Pioneering microfluidic bioprinting company Aspect Biosystems launched a new grant program for research labs, enhancing the use of 3D bioprinting technology. The Vancouver-based biotechnology firm will choose two winners that…

At a time when experts predict cancer will remain a massive health problem, advances in technology can make a big difference. Earlier this year, the World Health Organization (WHO) announced…

For over four years biotech company Cellink has been helping researchers pursue creative ways to promote organ regeneration, test novel drugs, develop vascularized bioconstructs, and more. Through collaborative partnerships and…

Studying cancer biology is among the top priorities for researchers around the world. From consortiums to universities, pharma companies, newcomers in the drug development industry, and research institutions, current research…

In the field of 3D bioprinting, the major, overarching goal is to be able to fabricate functional 3D printed human organs. Many bioprinting companies, such as Organovo and Aether, are making…

If you are starting to get the impression that there is little researchers and innovators cannot do with 3D printing, you are thinking in the right direction—as are so many…